MEDANTA.NS Balance Sheet
Global Health Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 22:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹1,707.84 Cr. | ₹1,812.92 Cr. | ₹1,975.26 Cr. | ₹3,778.71 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹326.98 Cr. | ₹386.28 Cr. | ₹528.52 Cr. | ₹132.21 Cr. | CapitalWorkInProgress |
| Goodwill | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | Goodwill |
| Other Intangible Assets | ₹5.17 Cr. | ₹4.28 Cr. | ₹6.47 Cr. | ₹16.05 Cr. | OtherIntangibleAssets |
| Non-current Investments | ₹0.05 Cr. | ₹0.05 Cr. | ₹2.71 Cr. | ₹2.55 Cr. | NoncurrentInvestments |
| Other Non-current Assets | ₹427.79 Cr. | ₹502.05 Cr. | ₹652.26 Cr. | ₹173.08 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | ₹2,536.48 Cr. | ₹2,795.34 Cr. | ₹3,233.11 Cr. | ₹4,230.08 Cr. | NoncurrentAssets |
| Inventories | ₹60.37 Cr. | ₹66.85 Cr. | ₹67.14 Cr. | ₹78.98 Cr. | Inventories |
| Trade Receivables | ₹194.20 Cr. | ₹215.31 Cr. | ₹291.86 Cr. | ₹411.19 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹767.24 Cr. | ₹424.61 Cr. | ₹230.20 Cr. | ₹127.33 Cr. | CashAndCashEquivalents |
| Current Investments | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | CurrentInvestments |
| Other Current Assets | ₹14.13 Cr. | ₹16.86 Cr. | ₹18.99 Cr. | N/A | OtherCurrentAssets |
| Total Current Assets | ₹1,579.49 Cr. | ₹1,508.73 Cr. | ₹1,533.12 Cr. | ₹1,674.92 Cr. | CurrentAssets |
| Total Assets | ₹4,115.96 Cr. | ₹4,304.07 Cr. | ₹4,766.23 Cr. | ₹5,905.00 Cr. | Assets |
| Equity Share Capital | ₹53.64 Cr. | ₹53.70 Cr. | ₹53.72 Cr. | ₹53.74 Cr. | EquityShareCapital |
| Other Equity | ₹2,374.57 Cr. | ₹2,851.93 Cr. | ₹3,332.69 Cr. | ₹3,907.83 Cr. | OtherEquity |
| Equity Attributable to Owners | ₹2,428.21 Cr. | ₹2,905.63 Cr. | ₹3,386.41 Cr. | ₹3,961.57 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | N/A | ₹-0.03 Cr. | ₹1.10 Cr. | ₹22.70 Cr. | NonControllingInterest |
| Total Equity | ₹2,428.21 Cr. | ₹2,905.59 Cr. | ₹3,387.51 Cr. | ₹3,984.28 Cr. | Equity |
| Long-term Borrowings | ₹737.12 Cr. | ₹283.47 Cr. | ₹264.10 Cr. | ₹1,127.06 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹1,115.20 Cr. | ₹780.75 Cr. | ₹759.91 Cr. | ₹1,293.60 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | ₹105.10 Cr. | ₹135.87 Cr. | ₹63.78 Cr. | ₹62.99 Cr. | BorrowingsCurrent |
| Trade Payables | ₹194.69 Cr. | ₹186.78 Cr. | ₹194.81 Cr. | ₹242.37 Cr. | TradePayablesCurrent |
| Other Current Liabilities | ₹98.35 Cr. | ₹92.28 Cr. | ₹151.18 Cr. | ₹158.56 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | ₹572.55 Cr. | ₹617.73 Cr. | ₹618.82 Cr. | ₹627.13 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | ₹4,115.96 Cr. | ₹4,304.07 Cr. | ₹4,766.23 Cr. | ₹5,905.00 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from MEDANTA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).